Systemic treatment of psoriatic patients with bexarotene dec…
Systemic treatment of psoriatic patients with bexarotene decreases epidermal proliferation and parameters for inflammation%252C and improves differentiation in lesional skin.
Article, Chapter
Full text availability for this item
Coverage:
- 1979-07~present; volume:1~present;issue:1~present